Fisher Wallace Labs develops, validates, and commercializes wearable brain stimulation technology for the treatment of anxiety, depression, insomnia, and other neuropsychiatric and cognitive disorders, with a self-described mission to increase access to rapid and safe mental healthcare.

Fisher Wallace Labs

Fisher Wallace Laboratories, Inc. | 1,192 followers on LinkedIn. Better tech for mental health. | Fisher Wallace Labs is on a mission to vastly increase access to mental healthcare. We develop and commercialize wearable brain stimulation technology for the treatment of depression, anxiety, and other neuropsychiatric and cognitive disorders. Our technology was recently proven to be rapidly effective in two large clinical trials for the treatment of Major Depressive Disorder and Generalized Anxiety Disorder, the latter of which was conducted in collaboration with the Seattle Police Department and Washington State University.

Ursus Advisory

Chip Fisher

Entrepreneur | Sales Leader | Team Builder

Yedidiah Teitelbaum

Chief Legal Officer | General Counsel | Strategic Business Partner | Investor | Board Member

Alexandra Bulkeley

Kelly Roman

Fisher Wallace Laboratories, Inc.

A big step towards improving how depression is treated:

On January 2nd, Fisher Wallace welcomed Dr. Maurizio Fava as an advisor to design the clinical trial we intend to conduct later this year to obtain FDA approval for the treatment of depression. Dr. Fava serves as Psychiatrist-in-Chief at Massachusetts General Hospital, and is also Director of the Mass General Research Institute. We are honored to have him as a collaborator as we work to make safe, rapid depression treatment accessible to everyone. The new protocol will be informed, in part, by our recent 255-subject study that documented the acute (4 week) treatment of moderate to severe depression, the results of which will soon be published by The Journal of Clinical Psychiatry. We intend to submit these results in support of a CE mark and UKCA mark for OAK.

FISH

COM:FISHERWALLACE

Fisher Wallace Labs